A study to investigate the safety and tolerability of dostarlimab in adult participants with chronic HBV infection on nucleos(t)ide analogue (NA) treatment

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509027-41-00

Acronym

222110

Enrollment

Registered

2024-11-11

Start date

Unknown

Completion date

2024-12-02

Last updated

2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic, Hepatitis B

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Bulgaria, France, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026